SMFM Statement: clarification of recommendations regarding cell-free DNA aneuploidy screening - 02/12/15
Society for Maternal-Fetal Medicine (SMFM) Publications Committee⁎
Abstract |
The purpose of this statement is to clarify that the Society for Maternal-Fetal Medicine (SMFM) does not recommend that cell-free DNA aneuploidy screening be offered to all pregnant women, nor does it suggest a requirement for insurance coverage for cell-free DNA screening in women at low risk of aneuploidy. However, SMFM believes, due to the ethics of patient autonomy, that the option should be available to women who request additional testing beyond what is currently recommended by professional societies.
Le texte complet de cet article est disponible en PDF.Key words : cell-free DNA aneuploidy screening, prenatal aneuploidy screening, diagnostic testing, genetic testing
| The author reports no conflict of interest. |
Vol 213 - N° 6
P. 753-754 - décembre 2015 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
